17.01.2013 09:02:00

Getinge Group: Getinge announces date of 2012 Q4 report and conference call

Regulatory News:

GETINGE will issue its Q4 report for 2012 on Friday 25th of January 2013 at 12:00 CET, followed by a conference call at 14:00 CET, hosted by Johan Malmquist, CEO, and Ulf Grunander, CFO.

To participate in the conference, please dial: Swedish dial in number: +46 8 5352 6408 UK dial in number: +44 20 3364 5381

US dial in number: +1 646 254 3366

Participant passcode: 7506740

Agenda

13:45 Call in to the conference

14:00 Review of the Q4 report

14:20 Q&A

15:00 Close of the conference

A recorded version of the conference can be accessed for 5 working days on the following number:

Sweden: +46 8 5051 3897

UK: +44 20 3427 0598
US: +1 347 366 9565
Code: 7506740

During the telephone conference a presentation will be held. To access the presentation, please use this link: http://www.livemeeting.com/cc/premconfeurope/join?id=7506740&role=attend&pw=pw9390

Alternatively enter the VisionCast site and log into your meeting using the Meeting ID and Password below: VisionCast: http://www.euvisioncast.com Your Name: (Enter your name) Web Meeting ID: 7506740 Web Meeting Password: pw9390

GETINGE GROUP is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. We operate under the three brands of ArjoHuntleigh, GETINGE and MAQUET. ArjoHuntleigh focuses on patient mobility and wound management solutions. GETINGE provides solutions for infection control within healthcare and contamination prevention within life sciences. MAQUET specializes in solutions, therapies and products for surgical interventions, interventional cardiology and intensive care.

The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act.

This information was brought to you by Cision http://www.cisionwire.com

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu Getinge ABmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Getinge AB 19,71 2,74% Getinge AB

Indizes in diesem Artikel

OMXS30 2 713,62 -0,39%